In reference to mail dated 11.02.2020, Prism Medico and Pharmacy has informed that it has enclosed the revised Standalone and Consolidated Financial Results for the Quarter Ended 31st December, 2019 in accordance with Schedule III format of Companies Act, 2013.
The above information is a part of company’s filings submitted to BSE.